{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:00:26Z","timestamp":1772136026620,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270905"],"award-info":[{"award-number":["81270905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    SPARC-deficient mice have been shown to exhibit impaired glucose tolerance and insulin secretion, but the underlying mechanism remains unknown. Here, we showed that SPARC enhanced the promoting effect of Muscarinic receptor agonist oxotremorine-M on insulin secretion in cultured mouse islets. Overexpression of SPARC down-regulated RGS4, a negative regulator of \u03b2-cell M3 muscarinic receptors. Conversely, knockdown of SPARC up-regulated RGS4 in Min6 cells. RGS4 was up-regulated in islets from\n                    <jats:italic>sparc<\/jats:italic>\n                    \u2212\/\u2212 mice, which correlated with decreased glucose-stimulated insulin secretion (GSIS). Furthermore, inhibition of RGS4 restored GSIS in the islets from\n                    <jats:italic>sparc<\/jats:italic>\n                    \u2212\/\u2212 mice, and knockdown of RGS4 partially decreased the promoting effect of SPARC on oxotremorine-M-stimulated insulin secretion. Phosphoinositide 3-kinase (PI3K) inhibitor LY-294002 abolished SPARC-induced down-regulation of RGS4. Taken together, our data revealed that SPARC promoted GSIS by inhibiting RGS4 in pancreatic \u03b2 cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-74593-w","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T06:02:55Z","timestamp":1602828175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic \u03b2 cells"],"prefix":"10.1038","volume":"10","author":[{"given":"Li","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengli","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neveen","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Shan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"74593_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA Defronzo","year":"2009","unstructured":"Defronzo, R. A. Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58, 773\u2013795. https:\/\/doi.org\/10.2337\/db09-9028 (2009).","journal-title":"Diabetes"},{"key":"74593_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky, J. M. & Glass, C. K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219\u2013246. https:\/\/doi.org\/10.1146\/annurev-physiol-021909-135846 (2010).","journal-title":"Annu. Rev. Physiol."},{"issue":"Suppl 3","key":"74593_CR3","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","volume":"53","author":"GC Weir","year":"2004","unstructured":"Weir, G. C. & Bonner-Weir, S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53(Suppl 3), S16-21 (2004).","journal-title":"Diabetes"},{"key":"74593_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fendo.2013.00071","volume":"4","author":"H Kwon","year":"2013","unstructured":"Kwon, H. & Pessin, J. E. Adipokines mediate inflammation and insulin resistance. Front. Endocrinol. 4, 71. https:\/\/doi.org\/10.3389\/fendo.2013.00071 (2013).","journal-title":"Front. Endocrinol."},{"key":"74593_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1096\/fasebj.8.2.8119487","volume":"8","author":"TF Lane","year":"1994","unstructured":"Lane, T. F. & Sage, E. H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8, 163\u2013173 (1994).","journal-title":"FASEB J."},{"key":"74593_CR6","doi-asserted-by":"publisher","first-page":"E440","DOI":"10.1073\/pnas.1104977108","volume":"108","author":"H Kucukdereli","year":"2011","unstructured":"Kucukdereli, H. et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc. Natl. Acad. Sci. U.S.A. 108, E440-449. https:\/\/doi.org\/10.1073\/pnas.1104977108 (2011).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"74593_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.biocel.2011.12.021","volume":"44","author":"AD Bradshaw","year":"2012","unstructured":"Bradshaw, A. D. Diverse biological functions of the SPARC family of proteins. Int. J. Biochem. Cell Biol. 44, 480\u2013488. https:\/\/doi.org\/10.1016\/j.biocel.2011.12.021 (2012).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"74593_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1083\/jcb.201011143","volume":"193","author":"LB Rivera","year":"2011","unstructured":"Rivera, L. B. & Brekken, R. A. SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-beta1 activity. J. Cell Biol. 193, 1305\u20131319. https:\/\/doi.org\/10.1083\/jcb.201011143 (2011).","journal-title":"J. Cell Biol."},{"key":"74593_CR9","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1073\/pnas.1030790100","volume":"100","author":"AD Bradshaw","year":"2003","unstructured":"Bradshaw, A. D., Graves, D. C., Motamed, K. & Sage, E. H. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc. Natl. Acad. Sci. U.S.A. 100, 6045\u20136050. https:\/\/doi.org\/10.1073\/pnas.1030790100 (2003).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"74593_CR10","doi-asserted-by":"publisher","first-page":"e53202","DOI":"10.1371\/journal.pone.0053202","volume":"8","author":"L Cheng","year":"2013","unstructured":"Cheng, L., Sage, E. H. & Yan, Q. SPARC fusion protein induces cellular adhesive signaling. PLoS ONE 8, e53202. https:\/\/doi.org\/10.1371\/journal.pone.0053202 (2013).","journal-title":"PLoS ONE"},{"key":"74593_CR11","doi-asserted-by":"publisher","first-page":"36483","DOI":"10.1074\/jbc.M504663200","volume":"280","author":"TH Barker","year":"2005","unstructured":"Barker, T. H. et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J. Biol. Chem. 280, 36483\u201336493. https:\/\/doi.org\/10.1074\/jbc.M504663200 (2005).","journal-title":"J. Biol. Chem."},{"key":"74593_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrendo.2010.18","volume":"6","author":"K Kos","year":"2010","unstructured":"Kos, K. & Wilding, J. P. SPARC: a key player in the pathologies associated with obesity and diabetes. Nat. Rev. Endocrinol. 6, 225\u2013235. https:\/\/doi.org\/10.1038\/nrendo.2010.18 (2010).","journal-title":"Nat. Rev. Endocrinol."},{"key":"74593_CR13","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.2337\/db09-0211","volume":"58","author":"K Kos","year":"2009","unstructured":"Kos, K. et al. Regulation of the fibrosis and angiogenesis promoter SPARC\/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes 58, 1780\u20131788. https:\/\/doi.org\/10.2337\/db09-0211 (2009).","journal-title":"Diabetes"},{"key":"74593_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12079-009-0064-4","volume":"3","author":"J Nie","year":"2009","unstructured":"Nie, J. & Sage, E. H. SPARC functions as an inhibitor of adipogenesis. J. Cell Commun. Signal. 3, 247\u2013254. https:\/\/doi.org\/10.1007\/s12079-009-0064-4 (2009).","journal-title":"J. Cell Commun. Signal."},{"key":"74593_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1074\/jbc.M808285200","volume":"284","author":"J Nie","year":"2009","unstructured":"Nie, J. & Sage, E. H. SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J. Biol. Chem. 284, 1279\u20131290. https:\/\/doi.org\/10.1074\/jbc.M808285200 (2009).","journal-title":"J. Biol. Chem."},{"key":"74593_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.acthis.2013.06.004","volume":"116","author":"Y Shen","year":"2014","unstructured":"Shen, Y. et al. SPARC is over-expressed in adipose tissues of diet-induced obese rats and causes insulin resistance in 3T3-L1 adipocytes. Acta Histochem. 116, 158\u2013166. https:\/\/doi.org\/10.1016\/j.acthis.2013.06.004 (2014).","journal-title":"Acta Histochem."},{"key":"74593_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071541","author":"Y Okura","year":"2019","unstructured":"Okura, Y. et al. Interaction of nerve growth factor beta with adiponectin and SPARC oppositely modulates its biological activity. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20071541 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"74593_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2018.02.129","volume":"497","author":"H Song","year":"2018","unstructured":"Song, H., Ding, L., Zhang, S. & Wang, W. MiR-29 family members interact with SPARC to regulate glucose metabolism. Biochem. Biophys. Res. Commun. 497, 667\u2013674. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.129 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"74593_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbrc.2010.05.033","volume":"396","author":"H Song","year":"2010","unstructured":"Song, H., Guan, Y., Zhang, L., Li, K. & Dong, C. SPARC interacts with AMPK and regulates GLUT4 expression. Biochem. Biophys. Res. Commun. 396, 961\u2013966. https:\/\/doi.org\/10.1016\/j.bbrc.2010.05.033 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"74593_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.freeradbiomed.2017.05.011","volume":"108","author":"KR Aseer","year":"2017","unstructured":"Aseer, K. R., Silvester, A. J., Kumar, A., Choi, M. S. & Yun, J. W. SPARC paucity alleviates superoxide-mediated oxidative stress, apoptosis, and autophagy in diabetogenic hepatocytes. Free Radical Biol. Med. 108, 874\u2013895. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.05.011 (2017).","journal-title":"Free Radical Biol. Med."},{"key":"74593_CR21","doi-asserted-by":"publisher","first-page":"30614","DOI":"10.1074\/jbc.M114.573980","volume":"289","author":"CL Ryall","year":"2014","unstructured":"Ryall, C. L. et al. Novel role for matricellular proteins in the regulation of islet beta cell survival: The effect of SPARC on survival, proliferation, and signaling. J. Biol. Chem. 289, 30614\u201330624. https:\/\/doi.org\/10.1074\/jbc.M114.573980 (2014).","journal-title":"J. Biol. Chem."},{"key":"74593_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/CS20180714","volume":"133","author":"C Atorrasagasti","year":"2019","unstructured":"Atorrasagasti, C. et al. SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice. Clin. Sci. 133, 351\u2013365. https:\/\/doi.org\/10.1042\/CS20180714 (2019).","journal-title":"Clin. Sci."},{"key":"74593_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03008207.2010.483747","volume":"52","author":"J Nie","year":"2011","unstructured":"Nie, J., Bradshaw, A. D., Delany, A. M. & Sage, E. H. Inactivation of SPARC enhances high-fat diet-induced obesity in mice. Connect. Tissue Res. 52, 99\u2013108. https:\/\/doi.org\/10.3109\/03008207.2010.483747 (2011).","journal-title":"Connect. Tissue Res."},{"issue":"Suppl 2","key":"74593_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1463-1326.2007.00781.x","volume":"9","author":"D Gautam","year":"2007","unstructured":"Gautam, D. et al. Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Diabetes Obes. Metab. 9(Suppl 2), 158\u2013169. https:\/\/doi.org\/10.1111\/j.1463-1326.2007.00781.x (2007).","journal-title":"Diabetes Obes. Metab."},{"key":"74593_CR25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.lfs.2012.04.010","volume":"91","author":"I Ruiz de Azua","year":"2012","unstructured":"Ruiz de Azua, I., Gautam, D., Jain, S., Guettier, J. M. & Wess, J. Critical metabolic roles of beta-cell M3 muscarinic acetylcholine receptors. Life Sci. 91, 986\u2013991. https:\/\/doi.org\/10.1016\/j.lfs.2012.04.010 (2012).","journal-title":"Life Sci."},{"key":"74593_CR26","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1073\/pnas.1003655107","volume":"107","author":"I Ruiz de Azua","year":"2010","unstructured":"Ruiz de Azua, I. et al. RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 107, 7999\u20138004. https:\/\/doi.org\/10.1073\/pnas.1003655107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74593_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1172\/JCI64782","volume":"123","author":"N Said","year":"2013","unstructured":"Said, N., Frierson, H. F., Sanchez-Carbayo, M., Brekken, R. A. & Theodorescu, D. Loss of SPARC in bladder cancer enhances carcinogenesis and progression. J. Clin. Investig. 123, 751\u2013766. https:\/\/doi.org\/10.1172\/JCI64782 (2013).","journal-title":"J. Clin. Investig."},{"key":"74593_CR28","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1A0713-415RR","author":"Z Luo","year":"2014","unstructured":"Luo, Z. et al. SPARC deficiency affects bone marrow stromal function, resulting in impaired B lymphopoiesis. J. Leukoc. Biol. https:\/\/doi.org\/10.1189\/jlb.1A0713-415RR (2014).","journal-title":"J. Leukoc. Biol."},{"key":"74593_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1593\/neo.81146","volume":"11","author":"MJ Socha","year":"2009","unstructured":"Socha, M. J. et al. Aberrant promoter methylation of SPARC in ovarian cancer. Neoplasia 11, 126\u2013135 (2009).","journal-title":"Neoplasia"},{"key":"74593_CR30","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1128\/MCB.25.22.9936-9948.2005","volume":"25","author":"YS Dai","year":"2005","unstructured":"Dai, Y. S., Xu, J. & Molkentin, J. D. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Mol. Cell. Biol. 25, 9936\u20139948. https:\/\/doi.org\/10.1128\/MCB.25.22.9936-9948.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"74593_CR31","doi-asserted-by":"publisher","first-page":"e99049","DOI":"10.1371\/journal.pone.0099049","volume":"9","author":"Y Luo","year":"2014","unstructured":"Luo, Y. et al. Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic beta-cells. PLoS ONE 9, e99049. https:\/\/doi.org\/10.1371\/journal.pone.0099049 (2014).","journal-title":"PLoS ONE"},{"key":"74593_CR32","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2337\/db12-0249","volume":"61","author":"J Zhang","year":"2012","unstructured":"Zhang, J. et al. Disruption of growth factor receptor-binding protein 10 in the pancreas enhances beta-cell proliferation and protects mice from streptozotocin-induced beta-cell apoptosis. Diabetes 61, 3189\u20133198. https:\/\/doi.org\/10.2337\/db12-0249 (2012).","journal-title":"Diabetes"},{"key":"74593_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/JME-18-0070","volume":"61","author":"L Hu","year":"2018","unstructured":"Hu, L. et al. NFATc3 deficiency reduces the classical activation of adipose tissue macrophages. J. Mol. Endocrinol. 61, 79\u201389. https:\/\/doi.org\/10.1530\/JME-18-0070 (2018).","journal-title":"J. Mol. Endocrinol."},{"key":"74593_CR34","doi-asserted-by":"publisher","DOI":"10.1055\/a-1008-9110","author":"L Hu","year":"2019","unstructured":"Hu, L. et al. Reduced compensatory beta-cell proliferation in Nfatc3-deficient mice fed on high-fat diet. Exp. Clin. Endocrinol. Diabetes https:\/\/doi.org\/10.1055\/a-1008-9110 (2019).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"74593_CR35","doi-asserted-by":"publisher","first-page":"24390","DOI":"10.1074\/jbc.M202490200","volume":"277","author":"YS Dai","year":"2002","unstructured":"Dai, Y. S., Cserjesi, P., Markham, B. E. & Molkentin, J. D. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. J. Biol. Chem. 277, 24390\u201324398. https:\/\/doi.org\/10.1074\/jbc.M202490200 (2002).","journal-title":"J. Biol. Chem."},{"key":"74593_CR36","doi-asserted-by":"publisher","first-page":"e68253","DOI":"10.1371\/journal.pone.0068253","volume":"8","author":"LW Harries","year":"2013","unstructured":"Harries, L. W. et al. A role for SPARC in the moderation of human insulin secretion. PLoS ONE 8, e68253. https:\/\/doi.org\/10.1371\/journal.pone.0068253 (2013).","journal-title":"PLoS ONE"},{"key":"74593_CR37","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1172\/JCI66432","volume":"123","author":"S Jain","year":"2013","unstructured":"Jain, S. et al. Chronic activation of a designer G(q)-coupled receptor improves beta cell function. J. Clin. Investig. 123, 1750\u20131762. https:\/\/doi.org\/10.1172\/JCI66432 (2013).","journal-title":"J. Clin. Investig."},{"key":"74593_CR38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/diabetes.49.3.392","volume":"49","author":"TP Iismaa","year":"2000","unstructured":"Iismaa, T. P. et al. Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 49, 392\u2013398 (2000).","journal-title":"Diabetes"},{"key":"74593_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/BJ20080042","volume":"412","author":"W Hu","year":"2008","unstructured":"Hu, W., Li, F., Mahavadi, S. & Murthy, K. S. Interleukin-1beta up-regulates RGS4 through the canonical IKK2\/IkappaBalpha\/NF-kappaB pathway in rabbit colonic smooth muscle. Biochem. J. 412, 35\u201343. https:\/\/doi.org\/10.1042\/BJ20080042 (2008).","journal-title":"Biochem. J."},{"key":"74593_CR40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1172\/JCI20016","volume":"114","author":"E Bernal-Mizrachi","year":"2004","unstructured":"Bernal-Mizrachi, E. et al. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J. Clin. Investig. 114, 928\u2013936. https:\/\/doi.org\/10.1172\/JCI20016 (2004).","journal-title":"J. Clin. Investig."},{"key":"74593_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28205","author":"Y Jing","year":"2019","unstructured":"Jing, Y. et al. SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K\/AKT\/PDGFB\/PDGFRbeta axis. J. Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.28205 (2019).","journal-title":"J. Cell Physiol."},{"key":"74593_CR42","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.bbapap.2007.06.002","volume":"1774","author":"AJ Kimple","year":"2007","unstructured":"Kimple, A. J. et al. The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Galpha-interaction face. Biochem. Biophys. Acta. 1774, 1213\u20131220. https:\/\/doi.org\/10.1016\/j.bbapap.2007.06.002 (2007).","journal-title":"Biochem. Biophys. Acta."},{"key":"74593_CR43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1017\/S003329171100167X","volume":"42","author":"E Kattoulas","year":"2012","unstructured":"Kattoulas, E. et al. Schizophrenia-related RGS4 gene variations specifically disrupt prefrontal control of saccadic eye movements. Psychol. Med. 42, 757\u2013767. https:\/\/doi.org\/10.1017\/S003329171100167X (2012).","journal-title":"Psychol. Med."},{"key":"74593_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/CS20080272","volume":"116","author":"S Gu","year":"2009","unstructured":"Gu, S., Cifelli, C., Wang, S. & Heximer, S. P. RGS proteins: Identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin. Sci. 116, 391\u2013399. https:\/\/doi.org\/10.1042\/CS20080272 (2009).","journal-title":"Clin. Sci."},{"key":"74593_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.neuron.2011.11.015","volume":"73","author":"TN Lerner","year":"2012","unstructured":"Lerner, T. N. & Kreitzer, A. C. RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron 73, 347\u2013359. https:\/\/doi.org\/10.1016\/j.neuron.2011.11.015 (2012).","journal-title":"Neuron"},{"key":"74593_CR46","doi-asserted-by":"publisher","first-page":"C1310","DOI":"10.1152\/ajpcell.00573.2008","volume":"296","author":"W Hu","year":"2009","unstructured":"Hu, W., Li, F., Mahavadi, S. & Murthy, K. S. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1\/2 and p38 MAPK and inhibited by the PI3K\/Akt\/GSK3beta pathway. Am. J. Physiol. Cell Physiol. 296, C1310-1320. https:\/\/doi.org\/10.1152\/ajpcell.00573.2008 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"74593_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1530\/EJE-11-0131","volume":"165","author":"D Wu","year":"2011","unstructured":"Wu, D., Li, L., Yang, M., Liu, H. & Yang, G. Elevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus. Eur. J. Endocrinol. Eur. Feder. Endocr. Soc. 165, 597\u2013601. https:\/\/doi.org\/10.1530\/EJE-11-0131 (2011).","journal-title":"Eur. J. Endocrinol. Eur. Feder. Endocr. Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74593-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74593-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74593-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:35:40Z","timestamp":1670344540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74593-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74593"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74593-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.11.902916","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"24 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y-S.D. is currently employed by Bristol-Myers Squibb Company. The rest of authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17581"}}